Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Flex Pharma Inc. (FLKS)

0.363   0.005 (1.45%) 02-15 16:00
Open: 0.3671 Pre. Close: 0.3578
High: 0.372 Low: 0.33
Volume: 1,623,027 Market Cap: 7M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.37 - 0.372 0.372 - 0.373
Low: 0.327 - 0.328 0.328 - 0.33
Close: 0.357 - 0.36 0.36 - 0.362

Technical analysis

as of: 2019-02-15 4:38:43 PM
Overall:       
Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.44     One year: 0.52
Support: Support1: 0.33    Support2: 0.30
Resistance: Resistance1: 0.38    Resistance2: 0.44
Pivot: 0.33
Moving Average: MA(5): 0.34     MA(20): 0.33
MA(100): 0.43     MA(250): 1.91
MACD: MACD(12,26):     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 64.39     %D(3): 49.40
RSI: RSI(14): 56.50
52-week: High: 8.98  Low: 0.26  Change(%): -91.6
Average Vol(K): 3-Month: 124903  10-Days: 53596

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
FLKS has closed above the upper band by 2.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 68.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to FLKS's normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-01-04T08:05:11-05:00
Flex Pharma up 44% on merger with Salarius Pharmaceuticals

2019-01-04T07:00:00-05:00
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18.07
Shares Float (M) 17.54
% Held by Insiders
% Held by Institutions 15.10
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.570
EPS Est. Current Year -2.340
EPS Est. Next Year -2.350
EPS Est. Next Quarter -0.750
Forward EPS -1.798
Book Value (p.s.) 0.550
PEG Ratio
Profit Margin
Operating Margin -2820.33
Return on Assets (ttm) -102.1
Return on Equity (ttm) -119.3
Qtrly Rev. Growth -39.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -26.22
Levered Free Cash Flow (M) -15.18

Stock Valuations

P/E -0.23
P/E Growth Ratio 0.01
P/BV 0.66
P/S 131188208.00
P/CF -0.25

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.